• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Placebo formulation impacts effectiveness of pain control in osteoarthritis

byNicholas WoolfandSai Folmsbee
July 31, 2015
in Chronic Disease
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. From a systematic review, intra-articular and topical placebos had greater effects on pain scores than oral placebos.

2. When accounting for differential effects of placebo treatments, intra-articular hyaluronic acid controlled pain best at 3 months.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Placebo treatments are used as inactive treatments to establish a baseline for comparison with the active treatments of interest in clinical trials. However, it is unclear whether different placebos have different levels of baseline efficacy. In this systematic review, placebo treatments for osteoarthritis (OA) pain were compared to each other and to several active treatments for OA. Results of the analysis show that intra-articular (IA) and topical placebo formulations had significantly greater effect sizes for pain control than the oral placebo formulation after 3 months. When comparing all possible treatment pairs with each other, it was found that IA hyaluronic acid had the greatest effect on pain scores at 3 months. On the other hand, when all placebos were compared with each active treatment as a single category, oral nonselective NSAIDs had the greatest effect on pain scores. This study was limited in that it did not account for the additional impact that the patient-doctor relationship may have on placebo efficacy. Overall, this study demonstrates that different modes of placebo administration can have different clinical effects, and this phenomenon should be accounted for when assessing the relative efficacies of different treatments for a particular disease.

Click to read the study, published in the Annals of Internal Medicine

Relevant Reading: Differential effectiveness of placebo treatments: A systematic review of migraine prophylaxis

RELATED REPORTS

Zavegepant (Zavzpret) may be effective for the management of migraine symptoms in Asian adults

Low-dose radiotherapy may be effective as a short-term therapeutic option in knee osteoarthritis

In-Depth [systematic review and meta-analysis]: This study included data from 149 randomized, controlled trials that compared at least 2 knee OA treatments and reported on their relative pain control efficacy. Placebo treatments included oral, IA, topical and oral plus topical formulations, while active treatments included acetaminophen, oral nonselective NSAIDs, oral COX-2–selective NSAIDs, topical NSAIDs, IA corticosteroids, and IA hyaluronic acid. IA and topical placebos had significantly greater effect sizes when compared to oral placebo after 3 months (0.29, 95%CI 0.09-0.49; and 0.20, 95%CI 0.02-0.38, respectively). IA hyaluronic acid had the highest mean differences in pain score when compared to oral, oral plus topical, topical and IA placebos at 3 months (0.60, 0.47, 0.40 and 0.31, respectively).

Image: CC/Wiki

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: osteoarthritisplacebo
Previous Post

Combination trametinib and dabrafenib show fewer side effects for metastatic melanoma than dabrafenib alone

Next Post

Uterus transplant recipients report good psychological outcomes

RelatedReports

Migraine collage: a woman resting with eyes closed and a finger at her temple, a zigzag aura, window blinds and sunglasses
Chronic Disease

Zavegepant (Zavzpret) may be effective for the management of migraine symptoms in Asian adults

November 6, 2026
A detailed illustration of a human knee joint, with visual elements representing therapy options, including pills and a prosthetic component.
Chronic Disease

Low-dose radiotherapy may be effective as a short-term therapeutic option in knee osteoarthritis

October 8, 2026
A woman experiencing a migraine, with visual representation of signaling pathways and a pill nearby, suggesting treatment with Rimegepant.
Chronic Disease

Rimegepant (Nurtec ODT) may be an effective alternative to triptans for symptom relief in migraines

October 6, 2026
A circular calendar divided into sections, with a blue pill resting on one section and representations of HIV particles surrounding it, symbolizing HIV treatment adherence.
Chronic Disease

Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy

September 24, 2026
Next Post

Uterus transplant recipients report good psychological outcomes

Topical analgesia for dyspareunia effective in breast cancer survivors

Ebola outbreak projected to exceed 20,000 cases by November

rVSV-ZEBOV Ebola vaccine highly effective and safe in trials conducted in Guinea

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Pelacarsen lowers lipoprotein(a) but does not reduce major cardiovascular events in patients with established cardiovascular disease
  • Durvalumab plus enfortumab vedotin was approved for perioperative treatment of muscle-invasive bladder cancer
  • CDC reports 5,412 confirmed measles cases in the United States in 2026
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.